India Consumer Discretionary: A Value-Led Boom Built On A Thin-Margin Floor

Reads the FY2025 close and the Q3 FY2026 quarter through Aurific same-store aggregates, ICRA/CRISIL/Bain macro work, and bellwether management commentary — to separate value-led from volume-led growth.

Analyst memo

The sector is moving from a broad, volume-fed cyclical recovery to a narrow, value-and-pricing boom: GST 2.0 and premiumisation are lifting same-store revenue hard (+30% FY26p) while the FY2025 close shows margin slipping (-0.7pp to 10.78%) and PAT crawling (+3% same-store). The directional FY2026p (~66% reported) does rebound — same-store PAT +49% and EBITDA +17% — but that recovery is concentrated in a handful of pockets, not broad-based. The edge sits with premium/aspirational franchises and EMS scale leaders; the struggle sits with mass-volume laggards and structurally shrinking Media.

01 / View

Executive Summary

The demand picture is genuinely strong, and the same-store numbers say so plainly. Aurific's common-panel aggregate (n=1175) shows revenue accelerating from +15% in FY2025 to +30% in FY2026p, with the quarterly cadence broadly higher year-on-year — +12% in Q3 FY2025 ending +28% in Q3 FY2026, though the ladder is not monotonic (it dips to +15% in Q1 FY2026 before re-accelerating; the exhibit below shows the full +12/+23/+15/+24/+28 path). The proximate catalyst is policy: GST 2.0 (effective 22-Sep-2025) cut small cars, sub-350cc two-wheelers, CVs and room ACs from 28% to 18% GST, lowering sticker prices ~6-8% and lighting a festive rebound that ICRA reports lifted real private consumption growth to 8.7% YoY in Q3 FY2026 (ICRA). Layered on top is a structural premiumisation wave — Bain's K-shaped thesis — that is doing more for value than volume.

Members only

Continue reading with Aurific

The full note — snapshot, sector trends, evidence checklist, decision rules and watch list — is available to Aurific members. Sign in to keep reading, or request access.

AI-Generated Research Disclosure: This report or analysis was generated in whole or in part using non-deterministic artificial intelligence systems and may contain factual, analytical, calculation, attribution, summarisation, or omission errors. AI-generated content may not have been independently reviewed by a human. Verify all material information against cited primary sources before relying on it. This content is provided solely for general informational and research purposes and is not investment advice, a personalised recommendation, a recommendation to buy, sell, or hold any security, or an offer or solicitation. Aurific AI Private Limited is not registered with SEBI as an investment adviser or research analyst. The analysis does not consider your objectives, financial circumstances, risk tolerance, tax position, or suitability. Securities investments are subject to market risk; past performance, valuations, forecasts, and model estimates do not guarantee future results. Consult a SEBI-registered investment adviser before acting.